Dollar General, HP, Johnson & Johnson and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Dollar General, Johnson & Johnson, HP and Teladoc.
With the trading day more than halfway over, the markets were moving higher going into the weekend. Each of the major indexes posted a gain of at least 0.4% on a strong push from the tech sector. This is also a welcome move from the dip that investors saw last week.
24/7 Wall St. is reviewing some big analyst calls seen on Friday. We have included the latest analyst call on each stock, as well as a recent trading history and the consensus targets among analysts.
For those that might have missed it, 24/7 Wall St. had an earlier round of analyst calls on Thursday that included Apple, Best Buy, Costco, Intel and more.
Adaptimmune Therapeutics PLC (NASDAQ: ADAP): Barclays initiated coverage with an Underweight rating with a $4 price target. Shares were trading around $5, in the 52-week range of $3.79 to $13.40. The consensus price target is $11.33.
Dollar General Corp. (NYSE: DG | DG Price Prediction): Telsey Advisory reiterated an Outperform rating and raised the price target to $235 from $225. The shares traded near $206 on Thursday, in a 52-week trading range of $173.50 to $225.25. The consensus price target is $235.78.
Guess Inc. (NYSE: GES): Telsey Advisory reiterated a Market Perform rating and raised the price target to $33 from $27. The stock traded near $29 on Thursday, in a 52-week range of $8.40 to $31.12. It has a consensus price target of $30.00.
HP Inc. (NYSE: HPQ): Cowen reiterated a Market Perform rating and raised the price target to $30 from $27. On Thursday, the stock traded around $29. The 52-week trading range is $14.86 to $36.00. The consensus price target is $32.43.
Johnson & Johnson (NYSE: JNJ): Morgan Stanley resumed coverage with an Overweight rating and a $187 price target. The stock traded near $170 on Thursday, in a 52-week range of $133.65 to $173.65. It has a consensus price target of $186.65.
Teladoc Health Inc. (NYSE: TDOC): Robert Baird initiated coverage with a Neutral rating and a $162 price target. The stock was changing hands at roughly $153 on Thursday, in a 52-week range of $129.74 to $308.00. It has a consensus price target of $231.41.
Four recently public stocks have had some wild price swings in 2021, but they are rated Buy across Wall Street and offer stellar technologies and applications. They also offer excellent entry points and have posted some solid results so far.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
